Available Until 12/31/2024
VIEW CART

Novel Therapies for Plaque Psoriasis: Aligning the Patient Perspective with Disease Management

This activity is supported by an educational grant from Arcutis Biotherapeutics, Inc.


Course Description: 

Plaque psoriasis disease severity ranges from mild cutaneous to extensive body surface area and multi-organ involvement, yet individuals with mild disease report a high disease burden and significant impact on physical and mental functioning. Advances in understanding the immune-mediated components of plaque psoriasis are driving targeted treatment approaches, adding to the complexity of formulary decisions and pharmacy benefit design. This session will focus on the impact of plaque psoriasis, defining the value of treatment options from the patient perspective, clinical evidence for novel therapies, and managed care considerations to optimize access to appropriate treatment.

Learning Objectives:

At the completion of this activity, participants should be able to:
  1. Define plaque psoriasis disease burden and the value of treatment outcomes from the patient perspective.
  2. Review the evidence supporting novel plaque psoriasis therapies.
  3. Discuss managed care benefit design challenges and strategies to optimize access to appropriate treatment.

Faculty(s)

Kayla Braestrup, PharmD, BCACP

Clinical Pharmacy Specialist – Dermatology and Gastroenterology

Kaiser Foundation Health Plan of the Northwest

Portland, OR

Leah M. Howard, JD

President & CEO

National Psoriasis Foundation

Alexandria, VA

Lynsey Smith, PharmD, BCACP

Clinical Pharmacy Specialist in Drug Use Management: Dermatology, Gastroenterology, Rheumatology

Kaiser Foundation Health Plan of Colorado

Denver, CO


Moderator(s)

Robert Nordyke, PhD

VP

National Pharmaceutical Council

Washington

Accreditation:

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN:0233-0000-23-014-L01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: March 22, 2023 •  Expiration Date: December 31, 2024
Activity Fee: Free for Members and for Non-Members

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2023. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements:

System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-23-014-H01-P 1.25 Contact Hours March 22, 2023 - December 31, 2024